CHANTELL COBY: Open Payments
NPI 1609264969 · MOOREFIELD, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$380 in 20 payments from 11 companies in 2025. Trend: 2023 $244 · 2024 $659 · 2025 $380
Food & beverage: $380
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $87 |
| ABBVIE INC. | 4 | $65 |
| Janssen Pharmaceuticals, Inc | 2 | $41 |
| Amgen Inc. | 2 | $38 |
| Supernus Pharmaceuticals, Inc. | 2 | $28 |
| Mallinckrodt Hospital Products Inc. | 1 | $24 |
| Lilly USA, LLC | 1 | $23 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $21 |
| Otsuka America Pharmaceutical, Inc. | 1 | $19 |
| Novo Nordisk Inc | 1 | $17 |
Products named: CAPLYTA, VRAYLAR, OTEZLA, Qelbree, ACTHAR, INVEGA SUSTENNA, MOUNJARO, QULIPTA.
Industry payments across WV — which companies pay providers there.
